Press Releases
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™
October 6, 2026
Read More
Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead
July 16, 2026
Read More
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead
Minneapolis, United States
June 30, 2026
Read More
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
Minneapolis, United States
January 8, 2026
Read More
Saluda Medical Raises $150M USD to Fuel Growth Following ASX IPO
Minneapolis, United States
December 9, 2025
Read More
Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the Evoke® SmartLoop™ System
Minneapolis, United States
July 17, 2025
Read More
For more information, please contact:
Investor and Media Contact:
Sam Wells
NWR Communications
+61 (0) 427 630 152
sam@nwrcommunications.com.au